In the UK , Kadcyla was not recommended for use by the National Health Service by advisory body NICE , reportedly .
An acceptable pricing agreement could not be reached with Roche .
In the UK , Kadcyla was not recommended for use by the National Health Service by advisory body NICE , reportedly because an acceptable pricing agreement could not be reached with Roche .